Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Lupus Nephritis by Using Mycophenolate Mofetil

An estimated 0.9% to 2.4% of patients with systemic lupus erythematosus (SLE) also have hemophagocytic lymphohistiocytosis (HLH). HLH associated with autoimmune diseases is often refractory to corticosteroid treatment; thus, additional immunosuppressive drugs, such as cyclosporine, cyclophosphamide,...

Full description

Saved in:
Bibliographic Details
Main Authors: Takashi Nawata, Makoto Kubo, Kosaku Shiragami, Yukinori Nakamura, Masafumi Yano
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Case Reports in Rheumatology
Online Access:http://dx.doi.org/10.1155/2017/4159727
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562730960158720
author Takashi Nawata
Makoto Kubo
Kosaku Shiragami
Yukinori Nakamura
Masafumi Yano
author_facet Takashi Nawata
Makoto Kubo
Kosaku Shiragami
Yukinori Nakamura
Masafumi Yano
author_sort Takashi Nawata
collection DOAJ
description An estimated 0.9% to 2.4% of patients with systemic lupus erythematosus (SLE) also have hemophagocytic lymphohistiocytosis (HLH). HLH associated with autoimmune diseases is often refractory to corticosteroid treatment; thus, additional immunosuppressive drugs, such as cyclosporine, cyclophosphamide, or tacrolimus, are required. Here, we describe the case of a 44-year-old Japanese woman who developed HLH associated with lupus nephritis. Initially, her HLH was refractory to treatment with a corticosteroid, tacrolimus, and mizoribine. However, alternative treatment with a corticosteroid, mycophenolate mofetil, and tacrolimus improved both her HLH and lupus nephritis. This case suggests the possibility of mycophenolate mofetil as a key drug for treating HLH associated with SLE.
format Article
id doaj-art-477545163c6b4708962fce2d2a7d2df3
institution Kabale University
issn 2090-6889
2090-6897
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Case Reports in Rheumatology
spelling doaj-art-477545163c6b4708962fce2d2a7d2df32025-02-03T01:21:56ZengWileyCase Reports in Rheumatology2090-68892090-68972017-01-01201710.1155/2017/41597274159727Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Lupus Nephritis by Using Mycophenolate MofetilTakashi Nawata0Makoto Kubo1Kosaku Shiragami2Yukinori Nakamura3Masafumi Yano4Department of Medicine and Clinical Science, Division of Cardiology and Clinical Immunology, Yamaguchi University Graduate School of Medicine, Ube, JapanDepartment of Medicine and Clinical Science, Division of Cardiology and Clinical Immunology, Yamaguchi University Graduate School of Medicine, Ube, JapanDepartment of Medicine and Clinical Science, Division of Cardiology and Clinical Immunology, Yamaguchi University Graduate School of Medicine, Ube, JapanDivision of Endocrinology, Metabolism, Hematological Science and Therapeutics, Yamaguchi University Graduate School of Medicine, Ube, JapanDepartment of Medicine and Clinical Science, Division of Cardiology and Clinical Immunology, Yamaguchi University Graduate School of Medicine, Ube, JapanAn estimated 0.9% to 2.4% of patients with systemic lupus erythematosus (SLE) also have hemophagocytic lymphohistiocytosis (HLH). HLH associated with autoimmune diseases is often refractory to corticosteroid treatment; thus, additional immunosuppressive drugs, such as cyclosporine, cyclophosphamide, or tacrolimus, are required. Here, we describe the case of a 44-year-old Japanese woman who developed HLH associated with lupus nephritis. Initially, her HLH was refractory to treatment with a corticosteroid, tacrolimus, and mizoribine. However, alternative treatment with a corticosteroid, mycophenolate mofetil, and tacrolimus improved both her HLH and lupus nephritis. This case suggests the possibility of mycophenolate mofetil as a key drug for treating HLH associated with SLE.http://dx.doi.org/10.1155/2017/4159727
spellingShingle Takashi Nawata
Makoto Kubo
Kosaku Shiragami
Yukinori Nakamura
Masafumi Yano
Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Lupus Nephritis by Using Mycophenolate Mofetil
Case Reports in Rheumatology
title Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Lupus Nephritis by Using Mycophenolate Mofetil
title_full Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Lupus Nephritis by Using Mycophenolate Mofetil
title_fullStr Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Lupus Nephritis by Using Mycophenolate Mofetil
title_full_unstemmed Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Lupus Nephritis by Using Mycophenolate Mofetil
title_short Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Lupus Nephritis by Using Mycophenolate Mofetil
title_sort successful treatment of hemophagocytic lymphohistiocytosis associated with lupus nephritis by using mycophenolate mofetil
url http://dx.doi.org/10.1155/2017/4159727
work_keys_str_mv AT takashinawata successfultreatmentofhemophagocyticlymphohistiocytosisassociatedwithlupusnephritisbyusingmycophenolatemofetil
AT makotokubo successfultreatmentofhemophagocyticlymphohistiocytosisassociatedwithlupusnephritisbyusingmycophenolatemofetil
AT kosakushiragami successfultreatmentofhemophagocyticlymphohistiocytosisassociatedwithlupusnephritisbyusingmycophenolatemofetil
AT yukinorinakamura successfultreatmentofhemophagocyticlymphohistiocytosisassociatedwithlupusnephritisbyusingmycophenolatemofetil
AT masafumiyano successfultreatmentofhemophagocyticlymphohistiocytosisassociatedwithlupusnephritisbyusingmycophenolatemofetil